• aTyr Pharma schedules a special shareholder meeting in San Diego on Oct. 16, 2026.
• Vote sought to authorize a reverse stock split, with the ratio set by the board within a 1-for-10 to 1-for-50 range.
• Proposal would amend the company’s certificate of incorporation to permit the reverse split if implemented.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aTyr Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001339970-26-000058), on August 31, 2026, and is solely responsible for the information contained therein.